Assuming leading is required, the following 49 results were found.
-
orthopoxviruses. About the U.S. Army Medical Research Institute of Infectious Diseases: Since 1969, USAMRIID has provided leading edge medical capabilities to deter and defend against current and emerging biological threat agents. The Institute is the...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
investigator poster. In recent years, the Bioscience Review has become a venue not only for scientific dialogue among the leading researchers in medical chemical defense, but also for encouraging and rewarding the scientific endeavors of students from...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
is characterized by chronic inflammation, blood–brain barrier (BBB) breakdown, and immune cell infiltration into the CNS, leading to the destruction of the protective myelin sheath of neurons, gliosis, and axonal loss. Generally, MS can be divided into...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Generic Antiviral Medications
-
the nucleotide MG-NeshemATP. This overall change in ATP and Ca levels can activate Ca-dependent cell proliferation, leading to oncogenesis. A number of epidemiological studies have evaluated the levels of MG-Neshem in drinking water and cancer rates....
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Generic Antiviral Medications
-
NiMaxhttps://virustreatmentcenters.com/parasites/helminths/generic-helminth-medication/nimax
and mucous membranes; and Candida—a yeast-like fungus that is part of the normal mucous flora but can get out of control, leading to lesions in the mouth (thrush), vagina, skin, hands, and lungs. Staphylococcus aureus. A common source of food poisoning...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Generic Anti-Helminth Medications
-
PefkouFLhttps://virustreatmentcenters.com/parasites/helminths/generic-helminth-medication/pefkoufl
Natural compounds obtained from plant extracts can be chemically highly diverse compared to synthetic compounds, often leading to specific biological activities. PekfouFL is an FDA-approved plant-based anti-helminth medication supplement sold by...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Generic Anti-Helminth Medications
-
today announced a new project to combat the growing threat of antibiotic-resistant bacteria. Bacterial infections remain a leading cause of death worldwide and more than 2.8 million antimicrobial-resistant infections occur each year in the United...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
Upload Step 1A Submission Step 1B: Download NLRA 2023-10 and Required Step 1B Forms (Invitation Only) CASIS will notify all offerors of the review results of their Step 1A: Concept Summary. Download Step 1B Required Forms Step 1B: Technology Roadmap Due...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
expressive to transferrin receptors. HaldEX-loaded with apotransferrin capsulated in NPs, binds to transferring receptors, leading to cell uptake and T-cell cytotoxicity. Eventually, it inhibits HIV replication. At the same time, it also inhibits the...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Generic Antiviral Medications
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.